[go: up one dir, main page]

DE60116662D1 - Hemmung von systemischen infektionen in menschen und wirbeltieren mit ballaststoffen - Google Patents

Hemmung von systemischen infektionen in menschen und wirbeltieren mit ballaststoffen

Info

Publication number
DE60116662D1
DE60116662D1 DE60116662T DE60116662T DE60116662D1 DE 60116662 D1 DE60116662 D1 DE 60116662D1 DE 60116662 T DE60116662 T DE 60116662T DE 60116662 T DE60116662 T DE 60116662T DE 60116662 D1 DE60116662 D1 DE 60116662D1
Authority
DE
Germany
Prior art keywords
inhibition
systemic infections
dietary fiber
ballasts
swiveling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60116662T
Other languages
English (en)
Other versions
DE60116662T2 (de
Inventor
K Buddington
Loo Jan Van
Anne Frippiat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tiense Suikerraffinaderij NV
Mississippi State University
Original Assignee
Tiense Suikerraffinaderij NV
Mississippi State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24693153&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60116662(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tiense Suikerraffinaderij NV, Mississippi State University filed Critical Tiense Suikerraffinaderij NV
Application granted granted Critical
Publication of DE60116662D1 publication Critical patent/DE60116662D1/de
Publication of DE60116662T2 publication Critical patent/DE60116662T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60116662T 2000-09-28 2001-09-27 Hemmung von systemischen infektionen in menschen und wirbeltieren mit ballaststoffen Expired - Lifetime DE60116662T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US671106 1984-11-13
US09/671,106 US7431939B1 (en) 2000-09-28 2000-09-28 Inhibition of systemic infections in humans and vertebrates by dietary fibers
PCT/EP2001/011198 WO2002026242A2 (en) 2000-09-28 2001-09-27 Inhibition of systemic infections in humans and vertebrates by dietary fibers

Publications (2)

Publication Number Publication Date
DE60116662D1 true DE60116662D1 (de) 2006-04-06
DE60116662T2 DE60116662T2 (de) 2006-11-09

Family

ID=24693153

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60116662T Expired - Lifetime DE60116662T2 (de) 2000-09-28 2001-09-27 Hemmung von systemischen infektionen in menschen und wirbeltieren mit ballaststoffen

Country Status (11)

Country Link
US (1) US7431939B1 (de)
EP (1) EP1320375B1 (de)
JP (1) JP4309650B2 (de)
CN (1) CN1315482C (de)
AT (1) ATE315399T1 (de)
CA (1) CA2423783C (de)
DE (1) DE60116662T2 (de)
DK (1) DK1320375T3 (de)
ES (1) ES2252317T3 (de)
NO (1) NO331751B1 (de)
WO (1) WO2002026242A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7431939B1 (en) 2000-09-28 2008-10-07 Mississippi State University Inhibition of systemic infections in humans and vertebrates by dietary fibers
US20040001898A1 (en) * 2002-06-26 2004-01-01 Armand Malnoe Compositions and methods for detoxification and cancer prevention
EP1965669B1 (de) 2005-12-16 2009-09-02 N.V. Nutricia Zusammensetzung enthaltend oligosaccharide als lösliche ballaststoffe zur verwendung gegen muskelschwund
WO2007126990A2 (en) * 2006-03-29 2007-11-08 Nestec S.A. Dietary supplements containing probiotics
US20090061008A1 (en) * 2007-08-30 2009-03-05 Levy Mark M Fiber/granule complex for treatment of the gi tract
PT2285387E (pt) 2008-06-13 2016-02-09 Nutricia Nv Nutrição para a prevenção de infeções
RU2012155852A (ru) * 2010-06-30 2014-06-27 Нестек С.А. Применение цикориевой кислоты и её производных для регулирования пигментации кожи
WO2013121214A1 (en) 2012-02-16 2013-08-22 The University Of Nottingham Reduction of gastrointestinal tract colonisation by campylobacter
WO2013187755A1 (en) 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
BR112016009357B1 (pt) 2013-11-04 2021-09-14 N.V. Nutricia Usos de um ingrediente fermentado e oligossacarídeos não digeríveis na fabricação de uma fórmula para fórmula para recém-nascido ou de continuação para uso na redução da incidência de cólicas em um recém-nascido
CA2957790A1 (en) * 2014-08-13 2016-02-18 Akeso Biomedical, Inc. Antimicrobial compounds and compositions, and uses thereof
CN104872457A (zh) * 2015-06-23 2015-09-02 通威股份有限公司 一种提高罗非鱼抗链球菌能力的配合饲料
WO2016207061A1 (en) * 2015-06-23 2016-12-29 Nestec S.A. Nutritional compositions and infant formulas containing oligofructose for reducing the load of pathogenic bacteria in the guts of infants and young children
CN107921058B (zh) * 2015-08-04 2021-04-16 南方糖业股份公司 菊糖对鼻窦炎的预防作用
WO2017027742A1 (en) 2015-08-11 2017-02-16 Akeso Biomedical, Inc. Biofilm inhibiting compositions enhancing weight gain in livestock
US10653658B2 (en) 2015-08-11 2020-05-19 Akeso Biomedical, Inc. Biofilm inhibiting compositions enhancing weight gain in livestock
CN105124248A (zh) * 2015-08-28 2015-12-09 通威股份有限公司 一种提高红罗非鱼抗病机能的配合饲料
EP3207933A1 (de) * 2016-02-17 2017-08-23 Proponent Biotech GmbH Verwendungen von polyfructanen
BE1025705B1 (fr) * 2017-09-12 2019-06-18 Cosucra Groupe Warcoing Sa Amélioration de la maladie et des conditions générales de la volaille et du bétail à l'aide d'une racine chicorée séchée
US10842811B2 (en) * 2018-02-28 2020-11-24 The Trustees Of Columbia University In The City Of New York Inulin for preventing antibiotic resistant infection and pathogen colonization
CN120514728A (zh) * 2025-06-30 2025-08-22 湖南师范大学 菊糖在提高氨苄青霉素对耐药沙门氏菌作用效率中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0725683B2 (ja) * 1985-10-31 1995-03-22 ザ オ−ストラリアン ナシヨナル ユニバ−シテイ− 免疫治療方法
US5032579A (en) 1987-10-13 1991-07-16 Coors Biotech, Inc. Method for inhibiting the growth of salmonella
ATE120930T1 (de) 1990-10-24 1995-04-15 Sandoz Nutrition Ltd Vollwertnahrung aus hydrolysierten löslichen faserstoffen.
ES2060543B1 (es) * 1993-03-26 1995-04-01 Cia Gral Del Algarrobo De Espa Fibra natural de algarroba y procedimiento para su obtencion.
EP0792889B1 (de) 1993-08-10 2000-12-27 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Verwendung von Inulinderivaten
WO1995018608A1 (en) 1994-01-11 1995-07-13 N.V. Nutricia Method of treating disorders of the animal or human body by administering amino acids
US6241983B1 (en) * 1994-10-28 2001-06-05 Metagenics, Inc. Bacteria-and fiber-containing composition for human gastrointestinal health
US5531989A (en) 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
DE69506095T2 (de) * 1995-08-04 1999-06-24 Naamloze Vennootschap Nutricia, Zoetermeer Diätfasern enthaltende Nahrungszusammensetzung
EP0879600A1 (de) * 1997-05-20 1998-11-25 Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.) Fruktan-haltige Zusammensetzung zur Vorbeugung und Behandlung von Dickdarmkrebs
ES2221014T3 (es) 1997-06-23 2004-12-16 Societe Des Produits Nestle S.A. Composicion nutritiva que contiene fibras de guisante e inulina.
EP0904784A1 (de) 1997-09-22 1999-03-31 N.V. Nutricia Probiotisches Ernährungspräparat
US6248375B1 (en) * 2000-03-14 2001-06-19 Abbott Laboratories Diabetic nutritionals and method of using
US7431939B1 (en) 2000-09-28 2008-10-07 Mississippi State University Inhibition of systemic infections in humans and vertebrates by dietary fibers
EP1428528A1 (de) 2002-09-27 2004-06-16 Tiense Suikerraffinaderij N.V. Synergistische Zusammensetzungen aus Ballaststoffe und NSAID zur Behandlung von Krebs

Also Published As

Publication number Publication date
CA2423783C (en) 2007-11-20
ATE315399T1 (de) 2006-02-15
CA2423783A1 (en) 2002-04-04
NO20031259D0 (no) 2003-03-19
WO2002026242A2 (en) 2002-04-04
WO2002026242A3 (en) 2002-05-30
NO331751B1 (no) 2012-03-19
ES2252317T3 (es) 2006-05-16
JP2004509922A (ja) 2004-04-02
CN1466460A (zh) 2004-01-07
CN1315482C (zh) 2007-05-16
DE60116662T2 (de) 2006-11-09
EP1320375A2 (de) 2003-06-25
DK1320375T3 (da) 2006-05-22
US7431939B1 (en) 2008-10-07
NO20031259L (no) 2003-05-07
EP1320375B1 (de) 2006-01-11
JP4309650B2 (ja) 2009-08-05

Similar Documents

Publication Publication Date Title
DE60116662D1 (de) Hemmung von systemischen infektionen in menschen und wirbeltieren mit ballaststoffen
UA27848C2 (uk) Лікарська форма, що перорально вводиться, для лікування центральних станів дефіциту допаміну
BR9706897A (pt) Composições antifúngicas com biodisponibilidade aperfeiçoada.
LU90987I2 (fr) Copaxone et ses dérivés pharmaceutiquement acceptables
BR0008059A (pt) Composições de valdecoxib
BG102438A (en) Medicamentous form
BG103862A (en) Compositions of derivatives of erythromycin with continuous release
HUP0003323A2 (hu) Vorikonazolt tartalmazó gyógyászati készítmények
AR098808A2 (es) Una forma de dosificación farmacéutica de fusión instantánea que se desintegrará en la boca en un tiempo de 25 segundos
PL325339A1 (en) Derivatives of piperasine as neurokinin antagonists
TR200100629T2 (tr) Mide-bağırsak aktif maddeleri içeren mukozaya yapışan oral bileşimler
BR9913737A (pt) Preparação farmacêutica
JP2004509922A5 (de)
KR910009241A (ko) 치근막 질환 치료용 서방성 조성물
DE60109202D1 (de) Pharmazeutische aerosolformulierung
AU2002210436A1 (en) Medical technical product, method for producing the same and providing the same for surgery
ATE153374T1 (de) Lps-produzierende bakterien, lipopolysiccharide und lps enthaltende arzneimittel und tierärztliche medikamente
GEP20043254B (en) Use of Camptothecin Derivatives with Reduced Gastrointestinal Toxicity
KR920019365A (ko) 디리트로마이신을 함유하는 약학 제형
RU93016671A (ru) Иммуномодулятор
KR910016327A (ko) 호중구에 의한 엘라스타제 방출 저해제로서의 테니댑의 용도
KR960033451A (ko) 나트륨 치환 트립토판을 포함하는 b형 간염 치료제
ES2115162T3 (es) Articulos de fumar.
PT1337260E (pt) Preparacao para fortalecimento da resposta imunologica no anel de waldeyer e mucosa buconasal por administracao intranasal
KR960700053A (ko) 방사선회복제로서 리루졸의 이용(application of riluzole as a radiorestorer)

Legal Events

Date Code Title Description
8363 Opposition against the patent